ZeenatSafdarMDMS, FACP, FCCP, ATSF

Clinical Trials

• Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2006 May 01

  Completed

  Phase 4

• Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial Start of enrollment: 2010 Mar 01

  Completed

  Phase 3

• Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. Start of enrollment: 2011 Mar 01

  Completed

  Phase 2

• Effects of Spironolactone on Collagen Metabolism in Patients With Pulmonary Arterial Hypertension Start of enrollment: 2011 Jul 01

  Unknown status

  Phase 4

• Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jan 31

  Terminated

  Phase 2

• Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument Start of enrollment: 2013 Apr 01

  Completed

  Phase 3

• Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT Start of enrollment: 2014 May 31

  Completed

  Phase 2

• Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST Start of enrollment: 2016 Oct 04

  Terminated

  Phase 3

• Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER Start of enrollment: 2017 Apr 18

  Terminated

  Phase 3

• A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients Start of enrollment: 2018 Aug 30

  Recruiting

  Phase 3

• Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry Start of enrollment: 2014 Jun 01

  Recruiting

• A Long-term Follow-up Study of Sotatercept for PAH Treatment (MK-7962-004/A011-12) Start of enrollment: 2021 May 12

  Recruiting

  Phase 3

• Join now to see all